Measurement of outcome

被引:22
作者
Blazeby, JM [1 ]
机构
[1] Univ Bristol, Bristol Royal Infirm, Div Surg, Bristol BS2 8HW, Avon, England
来源
SURGICAL ONCOLOGY-OXFORD | 2001年 / 10卷 / 03期
关键词
oesophageal neoplasms; outcomes; health related QL; economic evaluation;
D O I
10.1016/S0960-7404(01)00024-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The outcomes of treatment of oesophageal cancer include traditional biological and physical measures, such as mortality and morbidity data, disease free and overall survival, clinical and pathological response rates and symptom control. Such factors are essential and should be recorded prospectively for clinical audit. Using this type of information alone to evaluate effectiveness of treatment is inadequate, however, because the diagnosis and treatment of oesophageal cancer has a major impact on functional wellbeing (including psycho-social function), general health perceptions and overall quality of life (QL)/satisfaction with health and health care. These aspects of patients' well-being need to be considered, in addition to standard outcomes in the evaluation of treatment of oesophageal cancer. Recent needs to judge the economic efficiency of health care by comparing health outcomes with costs may also be part of treatment appraisal. This article reviews surgical, oncological, patient-based and economic outcomes in oesophageal cancer. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 58 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
AKIYAMA H, 1990, SURG CANC OESOPHAGUS
[3]   A PROPOSAL FOR STRUCTURED REPORTING OF RANDOMIZED CONTROLLED TRIALS [J].
ANDREW, E ;
ANIS, A ;
CHALMERS, T ;
CHO, M ;
CLARKE, M ;
FELSON, D ;
GOTZSCHE, P ;
GREENE, R ;
JADAD, A ;
JONAS, W ;
KLASSEN, T ;
KNIPSCHILD, P ;
LAUPACIS, A ;
MEINERT, CL ;
MOHER, D ;
NICHOL, G ;
OXMAN, A ;
PENMAN, MF ;
POCOCK, S ;
REISCH, J ;
SACKETT, D ;
SCHULZ, K ;
SNIDER, J ;
TUGWELL, P ;
TYSON, J ;
VARIN, F ;
WALOP, W ;
WALSH, S ;
WELLS, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (24) :1926-1931
[4]  
[Anonymous], 1996, J Clin Oncol, V14, P671
[5]   PROSPECTIVE RANDOMIZED TRIAL OF LASER THERAPY ONLY AND LASER THERAPY FOLLOWED BY ENDOSCOPIC INTUBATION FOR THE PALLIATION OF MALIGNANT DYSPHAGIA [J].
BARR, H ;
KRASNER, N ;
RAOUF, A ;
WALKER, RJ .
GUT, 1990, 31 (03) :252-258
[6]  
Bartels H, 1998, BRIT J SURG, V85, P840
[7]   Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer [J].
Blazeby, JM ;
Alderson, D ;
Winstone, K ;
Steyn, R ;
Hammerlid, E ;
Arraras, J ;
Farndon, JR .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) :1912-1917
[8]   QUALITY-OF-LIFE MEASUREMENT IN PATIENTS WITH ESOPHAGEAL CANCER [J].
BLAZEBY, JM ;
WILLIAMS, MH ;
BROOKES, ST ;
ALDERSON, D ;
FARNDON, JR .
GUT, 1995, 37 (04) :505-508
[9]  
Blazeby JM, 2000, CANCER, V88, P1781
[10]  
BLAZEBY JM, 1997, INT FIELD STUDY TEST